INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
INTELLIGENT BIO SOLUTIONS INC.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K/A on Oct 21, 2026
$1.53+0.03 (+2.00%)
Close on Oct 19, 2026
- Market cap
- $3.83M
- P/E (TTM)
- –
- Dividend yield
- –
INTELLIGENT BIO SOLUTIONS INC. revenue by segment
By business segment
By product or service
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | % of revenue | YoY |
|---|---|---|---|---|---|---|
| Sales of Goods - Cartidges [Member] | $2.49M | $1.76M | $1.55M | $724.30K | 59.0% | +41.1% |
| Sales of Goods - Readers [Member] | $902.26K | $711.74K | $938.90K | $335.86K | 21.4% | +26.8% |
| Other sales - accessories [Member] | $827.35K | $578.64K | – | – | 19.6% | +43.0% |
| Other Sales [Member] | – | $578.64K | $623.48K | $196.71K | – | – |
| IFPG [Member] | – | – | $3.11M | $1.26M | – | – |
By region
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | % of revenue | YoY |
|---|---|---|---|---|---|---|
| United Kingdom | $4.15M | $2.87M | $2.89M | $1.06M | 98.5% | +44.8% |
| Other Country [Member] | $40.20K | $132.70K | $162.22K | $189.19K | 1.0% | -69.7% |
| Asia Pacific [Member] | $12.47K | $29.17K | $43.96K | – | 0.3% | -57.3% |
| Americas [Member] | $8.75K | $22.64K | $11.41K | – | 0.2% | -61.3% |
| Australia | – | – | $43.96K | $6.49K | – | – |
From the segment and revenue-disaggregation notes of Intelligent Bio Solutions's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.